309results about How to "Avoid treatment" patented technology

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A method is provided for predicting an onset of a clinical episode, the method including sensing breathing of a subject, determining at least one breathing pattern of the subject responsively to the sensed breathing, comparing the breathing pattern with a baseline breathing pattern, and predicting the onset of the episode at least in part responsively to the comparison. Other embodiments are also described.

The invention relates to methods for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation in tissue of an antigen-sensitized mammal host by delivering an immunostimulatory oligonucleotide to the host. In addition, methods for using the immunostimulatory oligonucleotides to boost a mammal host's immune responsiveness to a sensitizing antigen (without immunization of the host by the antigen) and shifting the host's immune responsiveness to a Th1 phenotype to achieve various therapeutic ends are provided. Kits for practicing the methods of the invention are also provided.

The present invention provides orthotic devices for use in managing the treatment and prevention of lower extremity injuries, including foot ulcers. In various aspects, the present invention provides foot-worn orthotics which provide for improved compliance monitoring, and methods of their manufacture and use.

A system for monitoring at least one physiological parameter of a human subject. The system of the present invention features a device with which the human subject regularly interacts, and which is connected to the computational device of the human subject for automatic collection of at least one physiological parameter which is also of medical interest. The device features at least one physiological sensor for collecting the measurement of the physiological parameter. The computational device of the human subject then preferably operates a software program to analyze the data which is collected, in order for the human subject to receive an alert when necessary. Alternatively or additionally, the collected data is sent to a remote computational device which is in communication with the computational device of the human subject for analysis. Optionally, the present invention enables the human subject to receive an alert if a deterioration in the physiological condition of the human subject is detected, thereby enabling the human subject to start preventive medical treatment with trained medical personnel as soon as possible. Thus, the awareness of the human subject about any incipient medical problem is immediately improved, which may result in an increased probability of being able to successfully treat and / or otherwise ameliorate those problems.

Systems and methods for aiding individuals to complete tasks of daily living are provided. The situationally aware system comprises a controller, sensors, and effectors. The controller may include a program that describes a sequence of steps the user should perform to accomplish the task. In response to the information from the sensors and the user's compliance with the steps of the sequence, the controller instructs the effector(s) to relay at least one instructional cue to the user to aid in the performance of the task. The instructional cue may range from a simple blinking light, to detailed audio and / or visual instructions, to relaying a reward for the completion of the task. The instructional cue may also instruct the user to refrain from performing a task. The system is programmable, configurable, and may interface to the Internet.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A low-scatter polarization-preserving multilayer viewing screen. A substrate D, preferably a volume diffuser, for increasing the divergence of information-coded-light while preserving its polarization sense A as it passes therethrough has a discrimination of at least 2:1 within a viewing zone. An absorbing polarizer on one or both sides of D and aligned to pass polarization state A. In one embodiment, there is provided a polarization-state phase-shift layer for modifying the polarization state of forward-scatter and / or back-scatter that total internally reflects within the viewing screen into the state opposite of A. The phase-shift layer being located at any position between the polarizer and an outermost surface of the viewing screen through which said information-coded light passes.

The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating liver decompensation or hepatic encephalopathy. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating liver decompensation or hepatic encephalopathy.

Disclosed herein is a system for the collection, treatment and delivery of an autologous blood sample, comprising a first syringe having a first body portion. A first sample transfer portion has a first syringe inlet for drawing an untreated blood sample from a patient and a first syringe outlet for dispensing the untreated blood sample. A blood sample treatment chamber having a chamber inlet, the first syringe outlet being operable to establish a dedicated first fluid coupling with the chamber inlet to dispense the untreated blood sample to the blood sample treatment chamber. The blood sample treatment chamber having a chamber outlet for dispensing a treated blood sample following treatment. The second syringe has a second body portion and a second sample transfer portion, the second sample transfer portion having a passage with a first access location which is operable to form a dedicated second fluid coupling with the chamber outlet. The second body portion has a second syringe outlet, the passage having a second access location for fluid communication with the second syringe outlet, releasable lock means for forming a locked third fluid coupling between the second access location and the second syringe outlet. The lock means is operable in response to a release signal to release the third fluid coupling, the second syringe outlet being operable when released from the third fluid coupling to form a fourth fluid coupling with a blood sample delivery unit.

A method is provided for predicting an onset of a clinical episode, the method including sensing breathing of a subject, determining at least one breathing pattern of the subject responsively to the sensed breathing, comparing the breathing pattern with a baseline breathing pattern, and predicting the onset of the episode at least in part responsively to the comparison. Other embodiments are also described.

There is a need to improve access speed for a file in a storage system that is provided with multiple storage units having different access speeds.The storage system (10) includes an access frequency acquiring part (14) that divides a past constant accessed data acquisition period into multiple unit periods, and obtains an access frequency for file stored in any of the multiple storage units (30 and 31), a similarity degree calculating part (16) that obtains, for each file, a similarity degree between the access frequency to the file for each unit period, and the access frequency to every other file for each unit period, a grouping process part (17) that groups one or more other files having a similarity degree equal to or higher than a predetermined value, in an identical group, and a file relocation part (18) that places a file belonging to the identical group into a storage unit (30) having a high access speed, when the file stored in the storage units (30 and 31) is accessed and there exists any other file within the identical group to which the file belongs.

A system and process for treating retinal diseases includes passing a plurality of radiant beams, i.e., laser light beams, through an optical lens or mask to optically shape the beams. The shaped beams are applied to at least a portion of the retina. Due to the selected parameters of the beams—pulse length, power and duty cycle—the beams can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal phototherapy or photostimulation.

A system for monitoring at least one physiological parameter of a human subject. The system of the present invention features a device with which the human subject regularly interacts, and which is connected to the computational device of the human subject for automatic collection of at least one physiological parameter which is also of medical interest. The device features at least one physiological sensor for collecting the measurement of the physiological parameter. The computational device of the human subject then preferably operates a software program to analyze the data which is collected, in order for the human subject to receive an alert when necessary. Alternatively or additionally, the collected data is sent to a remote computational device which is in communication with the computational device of the human subject for analysis. Optionally, the present invention enables the human subject to receive an alert if a deterioration in the physiological condition of the human subject is detected, thereby enabling the human subject to start preventive medical treatment with trained medical personnel as soon as possible. Thus, the awareness of the human subject about any incipient medical problem is immediately improved, which may result in an increased probability of being able to successfully treat and / or otherwise ameliorate those problems.

Topical ointment for preventing and treating diaper rash are disclosed. The topical ointments comprise an emollient, a structurant, a rheology enhancer, and other optional components. In one preferred embodiment, the topical ointment comprises a particulate material such as zinc oxide as an optional component.

This invention relates to an automated process for efficiently treating an aqueous system with chlorine dioxide. The process results in high efficiency yields of chlorine dioxide on a continuous basis by minimizing the waste of precursor chemicals. Additionally, the process creates less environmental stress because the formation of unwanted by-products is minimized. The level of chlorine dioxide in the aqueous system treated and other parameters of the process are monitored and adjusted automatically to maintain them within acceptable levels.

A ceramic electronic component includes a ceramic element body having a substantially rectangular parallelepiped shape, and first and second external electrodes. The first and second external electrodes are provided on a first principal surface. Portions of the first and second external electrodes project further than the other portions in a thickness direction. A projecting portion of the first external electrode is provided at one end of the first external electrode in a length direction and a second projecting portion of the second external electrode is provided at another end of the second external electrode in the length direction. Thus, a concave portion is provided between the projecting portions, and a portion of the first principal surface provided between the first and second external electrodes is exposed.

A method for adapting motion profiles of a plurality of individually controllable transport elements for transporting containers in a container treatment system along a transport path, wherein the plurality of transport elements are movably arranged along the transport path, the method includes the following steps: determining a treatment state of at least one container carried along by a first transport element, and / or determining an operational state of at least one first container treatment unit which is arranged downstream with respect to a position of the first transport element along the transport path, wherein the first transport element is moved by an open- and / or closed-loop control unit of the container treatment system as part of a stream of transport elements, and wherein the motion profile of the first transport element is adapted by the open- and / or closed-loop control unit in response to the determined treatment state and / or the determined operational state.

The invention relates to a method for detection of abnormal PrP in a sample of blood or urine, said method comprising: (a) diluting the sample with buffer to comprise final concentrations of (i) 10 mM to 500 mM buffer agent; (ii) 1% to 10% w / v bovine serum albumin; and (iii) 1% to 8% w / v CHAPS; (b) adding steel particles and incubating to allow PrP binding; (c) washing the steel particles to remove diluted sample; and (d) detecting abnormal PrP captured on the steel particles using antibody capable of binding said abnormal PrP. The invention also provides compositions and kits.

Muscle toner is a progressive resistance fitness device to simultaneously activate muscle groups in arms, shoulders, upper chest, upper back, and neck areas. It strengthens muscle fibers, removes muscle tension, and restores motion to joints. Exercising with muscle toner is effective in the prevention and treatment of snoring, tension headaches, neck, and shoulder pains.

The present invention relates to a method for manufacturing glass containers for pharmaceutical use. This method allows obtaining containers with a low degree of alkalinity. In some preferred embodiments the process allows the manufacture of sterile containers and substantially free of particles ready to be used by the pharmaceutical industry.

Provided is a chromium-free metal surface treatment agent excellent in rust inhibitive performance which can be used in a surface treatment of metal products, in particular, galvanized metal products. The metal surface treatment agent consists essentially of a siliceous binder solution comprising water and / or alcohol as a solvent, and the concentration of the silica component is 8 to 25% by weight. In particular, a metal surface treatment agent containing an alcoholic solution of alkoxysilane oligomer having a weight averaged molecular weight of 1000 to 10000, which is obtained by hydrolyzed condensation polymerization of alkoxysilane, can suppress the occurrence of white rusting for a long time. It is preferred that 3 to 25 parts by weight of a dispersed nano-sized titanium dioxide powder having an average primary particle size of not more than 70 nm, per 100 parts by weight of the silica component be suspended in the siliceous binder solution. The rust inhibitive performance of the metal surface treatment agent can be further improved by using an alcohol-soluble polyvinyl butyral resin and by adding a silane coupling agent having a vinyl or epoxy group as a functional group, in combination with a dispersed nano-sized powder of titanium dioxide.

Together with other accessory products, includes a mixture of ion-exchange resins, cationic and anionic, charged with Ca2+, F- and PO43- ions, in an approximate molar ratio of 2:1:1, respectively. Particularly preferred is a material in which the resins also have a charge of Zn2+ ions representing a proportion of less than 1%, preferably close to 0.2% of the dry weight of the resin. The preferred resins are those whose base is cross-linked polystyrene with 2-14% divinylbenzene. The material is useful as first filler in the treatment of caries, especially deep caries, leading to remineralization of the dentin with a composition very close to the original composition, together with high microhardness. It is also useful as a component of dentifrice products such as pastes, elixirs and dental floss.

A method is provided for predicting an onset of a clinical episode, the method including sensing breathing of a subject, determining at least one breathing pattern of the subject responsively to the sensed breathing, comparing the breathing pattern with a baseline breathing pattern, and predicting the onset of the episode at least in part responsively to the comparison. Other embodiments are also described.

To provide an amino phosphate derivative having an excellent sphingosine-1-phosphate (S1P) receptor modulatory action.As a result of continued intensive research to create a highly safe compound which has an S1P receptor modulatory action, is has been discovered that an amino phosphate derivative represented by the following general formula (1),has a strong S1P receptor modulatory action.

The present invention relates to a system for hemostasis and prevention of adhesion for use in endoscopic surgery which allows quick and precise transfer of biopolymer particles in a constant amount onto a surgical site without agglomeration. The system utilizes a powder agitating container including a biopolymer case, a noninflammable gas supply line for supplying a noninflammable gas into the case, and a mixture transfer line for transferring a mixture of the noninflammable gas and the biopolymer. The container is fixed to the control box, the mixture is sprayed through a spray nozzle, and a gelling solution is sprayed from near the mixture.

The invention relates to a specialized subpopulation of natural killer cells that have enhanced effector functions and the potential to kill malignant tumor cells or infected cells when the natural killer cells are exposed to an antibody bound to the tumor cells or the infected cells.